Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

Who is this study for? Older patients with metastatic gastric cancer
What treatments are being studied? Provider Didactic Intervention
Status: Unknown
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to enhance the care of older metastatic gastric cancer (mGC) patients by increasing awareness among oncology providers of the unique aspects of care required for older patients. The goal of the study is to educate providers on the utility of geriatric assessment in guiding therapy of older mGC patients. The investigators will also assess the feasibility and benefit of incorporating geriatric self-assessments into clinical practice. The study will include four phases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 70
Healthy Volunteers: f
View:

• Ability to read and understand English, ability to sign consent, and complete a self-assessment evaluation.

• Evidence of mGC (mGE junction cancer allowed). Patients can be enrolled at any stage of their treatment or disease course.

• Ongoing active therapy for mGC. Patients can be treated with any type of therapy including chemotherapy, immunotherapy or Her-2 targeted therapy.

• Life expectancy ≥3 months.

Locations
United States
Pennsylvania
Fox Chase Cancer Center
RECRUITING
Philadelphia
Temple University Hospital
NOT_YET_RECRUITING
Philadelphia
Contact Information
Primary
Efrat Dotan, MD
Efrat.Dotan@fccc.edu
215-214-4283
Time Frame
Start Date: 2020-09-22
Completion Date: 2023-12-31
Participants
Target number of participants: 100
Treatments
Experimental: Provider Didactic Intervention
* Phase 1 - Providers complete a needs assessment questionnaire, which evaluates the approach to older mGC patients at each site.~* Phase 2 - Providers participate in an hour-long didactic session and begin enrolling eligible metastatic gastric cancer (mGC) patients. Enrolled mGC patients complete a comprehensive geriatric assessment (CGA). Providers complete the treatment plan and review of geriatric assessment questionnaires, which also includes an evaluation of their overall view of the utility of the geriatric assessment.~* Phase 3 - Follow-up chart reviews (2-3 months post intervention) are completed to assess for actual implementation of recommended interventions identified by the geriatric assessment.
Related Therapeutic Areas
Sponsors
Leads: Fox Chase Cancer Center
Collaborators: Eli Lilly and Company, National Comprehensive Cancer Network

This content was sourced from clinicaltrials.gov